Salicylate, one of the most widely used drugs, is known to induce reversible tinnitus and hearing loss. Salicylate interferes with outer hair cells (OHCs), which are believed to underlie normal auditory frequency selectivity and sensitivity. In the present experiments, the effects of salicylate and lanthanides on OHC motility and nonlinear capacitance were investigated by using isolated guinea-pig OHCs while attempting to avoid inadvertent intracellular pressure change, which itself can affect OHC motility and capacitance. Either extracellularly or intracellularly applied salicylate reduced nonlinear peak capacitance (Cm pk ) and shifted the voltage at peak capacitance to depolarized levels. Concentration-response curves for reduction in Cm pk by salicylate and GdCl 3 revealed a half-maximal concentration and Hill coefficient of 1.6 mM and 1.0, and 0.6 mM and 1.2, respectively. In comparable groups of OHCs, the normal Cm pk values of which were near 40 pF, average Cm pk decreased to 28 and 36 pF for intracellularly and extracellularly applied salicylate, respectively. Salicylate reduced, but did not completely block, the voltage-induced length change. Extracellularly, but not intracellularly, applied lanthanide blocked voltage-induced movement and capacitance almost completely. After intracellular trypsin treatment, salicylate reduced voltage-dependent capacitance reversibly, suggesting that salicylate directly acts on the sensor/motor and not via effects on intracellular structures, such as the subsurface cisternae. The results are consistent with the hypothesis that the dissociated, charged form of salicylate directly interacts with the sensor/ motor on the inner aspect of the OHC plasma, whereas lanthanides interact on the outer aspect.
The outer hair cell (OHC), one of the two receptor cell types in the mammalian organ of Corti, is thought to play a crucial role in hearing by providing a local mechanical feedback into the basilar membrane via its unique voltage-dependent length changes (Brownell et al., 1985; Ashmore, 1987; Santos-Sacchi and Dilger, 1988; Dallos, 1992) . This feedback sharpens the passive mechanical vibration of the cochlear partition. Recent studies demonstrate that the OHC has a nonlinear gating charge movement or, equivalently, a voltage-dependent capacitance that presents characteristics similar to those of OHC motility, indicating that membrane-bound voltage sensor/motor elements control OHC length (Ashmore, 1989 (Ashmore, , 1992 Dallos et al., 1991; Santos-Sacchi, 1991 Iwasa, 1994) .
Salicylate, which is used as an analgesic and anticoagulant, is one of the most widely used drugs. Salicylate is known to produce reversible tinnitus and hearing loss (Myers and Bernstein, 1965; Mongan et al., 1973) . Several lines of indirect evidence suggest that salicylate exerts these effects via the OHC (McFadden and Plattsmier, 1984; Long and Tubis, 1988; Puel et al., 1989; Kujawa et al., 1992; Carlyon and Butt, 1993) . Indeed, direct studies on the OHC have shown that the nonlinear capacitance and/or motility of the cell can be modified by salicylate Tunstall et al., 1995) . Shehata et al. (1991) reported that salicylate reduces OHC turgor pressure and motility. More recently, Tunstall et al. (1995) showed that salicylate reduces OHC membrane capacitance and concluded that salicylate is effective in the membrane-permeant uncharged form. Other treatments that are known to affect OHC motility and capacitance include lanthanides and altered turgor pressure, the latter acting via membrane stress (Santos-Sacchi, 1991; Iwasa, 1993; Gale and Ashmore, 1994b; Kakehata and Santos-Sacchi, 1995) .
Because whole-cell patch-pipette recording inadvertently can permit changes in OHC turgor pressure (Kakehata and SantosSacchi, 1995) , we examined the effect of salicylate and lanthanides on OHC nonlinear capacitance and voltage-induced mechanical responses while attempting to avoid such interference. The results suggest that each investigated agent seems to work via a different mechanism on the OHC sensor/motor and that the effects of both agents are independent of turgor pressure. Furthermore, the data indicate that the dissociated, charged form of salicylate interacts with the sensor/motor on the inner aspect of the plasma membrane, whereas lanthanides interact with the sensor/motor on the outer aspect.
MATERIALS AND METHODS
OHCs were freshly isolated from the organ of Corti of the guinea-pig cochlea (Kakehata et al., 1993) and were whole-cell voltage-clamped by an Axon 200 amplifier with patch pipettes having initial resistances of 2-3 M⍀ or ϳ10 M⍀, corresponding to tip sizes of 1-2 m or ϳ0.5 m, respectively (Hamill et al., 1981) . Residual series resistance (R s ; after electronic compensation) ranged from 3 to 7 M⍀ and from 20 to 30 M⍀, respectively. Ionic blocking solutions were used to remove voltagedependent ionic conductances so that capacitive currents could be analyzed in isolation (Santos-Sacchi, 1991; Huang and Santos-Sacchi, 1993) . The patch-pipette solution contained (in mM): 140 CsCl, 2 MgCl 2 , 10 EGTA, and 10 HEPES, pH 7.2; osmolarity was adjusted with dextrose to 300 mOsm. The external solution contained (in mM): 100 NaCl, 20 TEA, 20 CsCl, 2 CoCl 2 , 1.52 MgCl 2 , 10 HEPES, and 5 dextrose, pH 7.2, at 300 mOsm. In some experiments, extracellular CaCl 2 (2 mM) was included, without any effect. Drugs were applied by using the Y-tube method (Murase et al., 1990 ) during simultaneous whole-chamber perfusion. Experiments were performed at room temperature.
A tracking procedure was used to monitor continuously the voltage at peak nonlinear capacitance (V pkCm ) after obtaining whole-cell configuration (Kakehata and Santos-Sacchi, 1995) . The program Clampex (Axon Instruments, Foster City, CA) was modified to perform the V pkCm tracking procedure on-line, and membrane potential was corrected for the effects of residual series resistance. Peak capacitance (Cm pk ) values also were monitored during the tracking procedure by using transient analysis of capacitive currents induced by a Ϫ10 mV step.
Detailed, corroborative evaluation of membrane capacitance was made at different potentials by transient analysis of currents induced by a voltage stair-step stimulus, and the capacitance function was fit to the first derivative of a two-state Boltzmann function relating nonlinear charge to membrane voltage (dQ/dV; Santos-Sacchi, 1991; Huang and SantosSacchi, 1993) :
Q max is the maximum nonlinear charge moved, V pkCm is voltage at peak capacitance or, equivalently, at half-maximal nonlinear charge transfer, V m is membrane potential, z is valence, C lin is linear membrane capacitance, e is electron charge, k is Boltzmann's constant, and T is absolute temperature. Pipette pressure was modified with a syringe connected to the Teflon tubing attached to the patch-pipette holder. Pressure was monitored via a T-connector to a pressure monitor (World Precision Instruments, Sarasota, FL). An in-house pipette pressure clamp was used to maintain constant pipette pressure when required. This device provided positive or negative pressure into the pipette via a motor-driven, gas-tight syringe by using feedback from the pressure monitor. Previously, we have found that when recording with large-tipped patch pipettes (1.5-3 M⍀, 1.5 m tip) containing iso-osmolar solutions, V pkCm shifts to hyperpolarized levels over the course of 10 min after patch membrane rupture (Kakehata and Santos-Sacchi, 1995) . This occurs because of a decrease in OHC intracellular pressure. In the present set of experiments, three conditions were used to dismiss potential effects of uncontrolled, recording-induced intracellular pressure change during evaluation of salicylate and lanthanides on OHC capacitance and motility. First, the use of small-tipped pipettes provides for stable intracellular pressures, because no negative shifts of V pkCm are observed over periods of 30 min or longer. Under this condition, the potential effects of exogenous agents on intracellular pressure are unhampered. Second, with large-tipped pipettes, maintenance of constant pipette pressure provides for stable intracellular pressures, because V pkCm can be maintained constant. Third, with large-tipped pipettes after intracellular pressure dissipation (ϳ10 min), intracellular pressure is stable, because V pkCm remains constant. The drugs were evaluated under each condition.
All experiments were video taped with a Matrox (Montreal, Canada) video overlay board that combines EGA and video. Measures of voltageinduced (20 mV increments) mechanical responses were made from the video monitor with a differential optoresistor technique (Santos-Sacchi, 1989 , 1991 . Mechanical data were fit to a two-state Boltzmann function to determine the voltage at maximum sensitivity (V ␦Lmax ).
Dose-response data were averaged and are given as mean Ϯ SE. A continuous theoretical curve was drawn according to a modified Michaelis-Menten equation with the use of a least-squares fitting routine after normalization of the response,
in which ⌬C is the observed reduction of capacitance, C is the drug concentration, K D is the dissociation constant, and n is the Hill coefficient. All data analysis was performed with the software package MAT-LAB (Mathworks, Natick, MA). mechanism similar to that of turgor pressure change, which is believed to act via alterations in membrane stress (Iwasa, 1994; Kakehata and Santos-Sacchi, 1995) . The response time course of extracellularly applied salicylate was examined by using a tracking procedure to follow changes in V pkCm and Cm pk (Kakehata and Santos-Sacchi, 1995) . One millimolar salicylate reversibly reduced Cm pk and shifted V pkCm to depolarized levels (Fig. 3A) . These effects reached steady state in ϳ60 sec in this cell. An increase in the salicylate concentration accelerated the response (Fig. 3B ). The reduction of Cm pk was well fit with a single exponential. Tau of salicylate-induced reduction in Cm pk was 19.2 Ϯ 3.7 sec (mean Ϯ SE; n ϭ 5) and 11.4 Ϯ 2.4 sec (n ϭ 8) for 1 and 10 mM salicylate, respectively. With the use of fitted steady-state values, the average reduction of Cm pk and average shift of V pkCm (mean Ϯ SE) were 6.82 Ϯ 1.48 pF and 4.6 Ϯ 2.2 mV (1 mM; n ϭ 5), and 10.63 Ϯ 1.51 pF and 16.7 Ϯ 2.2 mV (10 mM; n ϭ 7). Nonlinear capacitance was evaluated more fully by using stair-step stimuli applied at least 120 sec after treatment. With this technique, average Cm pk was 46.86 Ϯ 1.25 (n ϭ 11) and 36.75 Ϯ 0.92 pF before and during application of 10 mM salicylate, respectively. The average reduction of Cm pk was 10.11 Ϯ 1.26 pF, which is comparable to the value of 10.63 Ϯ 1.51 pF obtained by the tracking technique.
RESULTS

Effects
Concentration-response curves for salicylate and gadolinium
Concentration-response curves for reduction in Cm pk by salicylate were obtained with the V pkCm tracking technique. Salicylate was applied by Y-tube in increasing concentrations, without intermittent washing, until a steady-state response was achieved. Pipette pressure was kept slightly positive (up to approximately ϩ0.07 kPa), to prevent turgor dissipation. Figure 4A shows a representative example. The effects of salicylate were just detectable at a concentration of ϳ300 M. The reduction increased sigmoidally as the salicylate concentration increased to 10 mM, above which the response was saturated. The half-maximal concentration (K 1/2 ) and the Hill coefficient (n) were 1.6 mM and 1.0, respectively. V pkCm shifted to depolarized levels at a concentration of Ͼ1 mM.
Concentration-response curves for GdCl 3 were obtained in a similar manner. Pipette pressure was kept positive (up to approximately ϩ0.14 kPa) to prevent turgor dissipation. Compared with salicylate, longer perfusion times were required to reach steady- Cm pk and V pkCm before and during application of lanthanides (3 or 10 mM GdCl 3 , n ϭ 7; 1 mM LuCl 3 , n ϭ 3; 1 mM CeCl 3 , n ϭ 1). Extracellularly applied lanthanides caused a negative shift in V pkCm with decreasing Cm pk in all cells tested (n ϭ 11). Reversibility was dependent on concentration. C, D, Cm pk and V pkCm before and during application of 10 mM salicylate. Extracellularly applied salicylate reduced Cm pk , although the direction of the shift in V pkCm was variable. The data are plotted in separate graphs for clarity. Of 21 cells tested, 13 showed a positive shift in V pkCm (C), and 8 cells showed a negative shift (D). Each symbol indicates a different cell. All treatments were done after V pkCm stabilized. state levels (Fig. 4B) . The effects of GdCl 3 were detectable at a concentration of 100 M. GdCl 3 reduced Cm pk in a concentrationdependent manner, and at 10 mM a near-maximal response was obtained. K 1/2 and n were 0.6 mM and 1.2, respectively. V pkCm shifted to hyperpolarized levels and reached very negative potentials of Ϫ67.4 Ϯ 3.9 mV (n ϭ 5). Two of the treated cells collapsed during data collection.
Effects of intracellularly applied salicylate
Recent evidence indicates that salicylate is highly permeable through the OHC membrane (Tunstall et al., 1995; Zhi et al., 1996) . However, the precise site in which salicylate acts on the OHC motility voltage sensor remains unknown. To investigate possible sites of salicylate effects, we applied salicylate intracellularly through patch pipettes and compared results with those obtained by extracellular application. Large-tipped pipettes were used, with pipette pressure clamped near zero. Tracking of Cm pk and V pkCm was started immediately after whole-cell configuration was obtained. In addition, stair-step stimuli in a wide voltage range (Ϫ150 to ϩ150 mV) were applied periodically. Figure 5 shows the immediate effect of intracellularly applied salicylate on voltage-dependent capacitance. In OHCs dialyzed with 5 mM salicylate, stair-step analysis revealed that reduction of Cm pk and the shift of V pkCm were time-dependent (data not shown). In two cells, the exponential time constant of Cm pk reduction was 11.25 and 6.89 sec. With 10 mM salicylate, Cm pk was reduced to a steady level of Ͻ30 pF within, at most, 5 sec after whole-cell configuration was obtained (Fig. 5) .
Because the effects of intracellularly applied salicylate are so rapid, it is impossible to obtain the initial normal capacitance value of the cell for comparison. Instead, we compared groups of intracellularly untreated and treated (10 mM) cells, the average cell length of which was 56.7 Ϯ 3.1 (n ϭ 11) and 58.5 Ϯ 3.4 m (n ϭ 11), respectively. OHC length correlates well with the membrane capacitance of the cell; thus, valid comparisons can be made between these groups. Average Cm pk was 46.87 Ϯ 1.25 and 28.20 Ϯ 0.67 pF in untreated and treated groups, respectively. In those control OHCs subsequently treated with extracellular 10 mM salicylate, the average Cm pk dropped to 36.75 Ϯ 0.92 pF. This value differs significantly from the value of 28.20 Ϯ 0.67 pF in the OHCs dialyzed with 10 mM salicylate (Student's t test Ͻ 0.001). These results indicate that salicylate works more effectively when applied intracellularly.
Voltage-induced OHC movement and voltage-dependent capacitance share many characteristics (Santos-Sacchi, 1991; Ashmore, 1992) . OHC voltage-dependent movement as well as voltage-dependent capacitance were reduced in a concentrationdependent manner by intracellular salicylate treatment (Fig. 6 ). In the absence of salicylate, voltage-induced length changes saturate at positive voltages. The voltage in which saturation initiates depends on OHC turgor pressure, because V ␦Lmax shifts with turgor pressure (Kakehata and Santos-Sacchi, 1995) . The maximum mechanical gain of the OHC, however, can remain fairly constant. Thus, to avoid the possible effect of turgor pressure on measures of OHC movement, we compared maximum mechanical gain of OHCs in the absence and presence of intracellular salicylate. The average gain was 19.53 Ϯ 1.98 nm/mV (n ϭ 3) in the absence of salicylate, which is in line with previous measures (Ashmore,1987; Santos-Sacchi and Dilger, 1988) . In the presence of 10 mM salicylate, voltage-induced length change did not saturate, and the movement function appeared linear within the voltage range of Ϫ150 to 150 mV. The average cell-length change obtained by a voltage step from a holding potential of Ϫ80 to 150 mV was 1.03 Ϯ 0.06 m (n ϭ 7). The average maximum mechanical gain was 5.17 Ϯ 0.43 nm/mV (n ϭ 9), which is about onefourth of the average gain in the absence of salicylate.
Comparison of effects between salicylate and lanthanide on OHC capacitance and movement
The effect of salicylate on OHC nonlinear capacitance is similar to that of lanthanides, which are known to block voltage-dependent OHC movement and capacitance (Santos-Sacchi, 1991; Kakehata and Santos-Sacchi, 1995) . However, significant differences exist between the effects of the two drugs and are revealed via dualtreatment experiments. In OHCs dialyzed with 10 mM salicylate, simultaneous measures of capacitance and voltage-dependent movements were made before and during extracellular application of 1 mM LuCl 3 . An example is shown in Figure 7 . At 4 min after whole-cell configuration, Cm pk was 30.4 pF, and z was 0.205. Extracellularly applied LuCl 3 further reduced Cm pk and z to a small extent, namely, 29.2 pF and 0.191, respectively. On the other hand, the effect elicited by LuCl 3 on the cell movement was significant. Voltage-induced movement was blocked almost completely; i.e., maximum mechanical gain was reduced from 8.04 to 0.70 nm/mV.
The effect of intracellularly applied lanthanide also was examined. Because EDTA-like calcium buffers are powerful lanthanide chelators, GdCl 3 (5 mM) was added to patch pipettes that did not include EGTA. Intracellularly applied GdCl 3 neither abolished the voltage-induced movement nor reduced nonlinear capacitance in all cells tested (data not shown; n ϭ 4). This result suggests that lanthanides work exclusively from the extracellular side of the OHC membrane.
Effects of salicylate on the limiting value of V pkCm
As OHC intracellular pressure is reduced, V pkCm shifts in the negative direction until it reaches a limiting value that occurs when the cell collapses (Kakehata and Santos-Sacchi, 1995) . Figure 8 illustrates the effects of salicylate on this limiting value. Intracellular pressure was reduced directly through the patch pipette. This treatment increased Cm pk and shifted V pkCm in the negative direction. In this case, V pkCm reached a limiting value of Ϫ55 mV when the OHC collapsed. After treatment with 10 mM salicylate extracellularly, the limiting value consistently moved in the positive direction while the OHC remained collapsed (n ϭ 5). The effect was reversible. This result further suggests that salicylate does not act via turgor pressure but affects the voltage dependence of the voltage sensor directly. It also may indicate that the minority of cells in which salicylate shifted V pkCm to negative potentials simultaneously may have experienced inadvertent changes in turgor pressure.
Effects of salicylate on V pkCm and Cm pk of trypsin-treated cells
It has been demonstrated that salicylate alters the structure of the OHC subsurface cisternae . To investigate whether normal subsurface cisternae are required for the effects of salicylate on the voltage sensor, we disrupted subsurface cisternal architecture by destroying the cortical cytoskeleton of the cell with intracellular trypsin. This treatment causes the OHC to become spherical and the subsurface cisternae to vesiculate and peel away from the plasmalemma (Huang and Santos-Sacchi, 1994) . Neither voltage-sensor gating charge movement nor the sensitivity of the sensor to intracellular pressure change is altered with this treatment (Kakehata and Santos-Sacchi, 1995) . Figure 9 illustrates the persisting, reversible effects of salicylate on trypsintreated OHCs. After the cell became fully spherical at ϳ13 min, 10 mM salicylate was applied extracellularly. Detailed measures of voltage-dependent capacitance also were made by using stair-step stimuli before, during, and after application of salicylate. Salicylate consistently and reversibly reduced voltage-dependent capacitance (n ϭ 3), suggesting that salicylate acts directly on the membrane-bound motor/sensor and not via the subsurface cisternae.
DISCUSSION
Previously, we demonstrated that intracellular pressure directly shifts the voltage dependence of membrane capacitance and motility in OHCs (Kakehata and Santos-Sacchi, 1995) . Increasing pressure shifts V pkCm and V ␦Lmax to positive potentials while simultaneously suppressing Cm pk ; decreasing pressure has the opposite effects. In addition, even with iso-osmolar intra-and extracellular solutions, V pkCm slowly moves to more hyperpolarized voltages after whole-cell configuration is established. This phenomenon is believed to underlie the variability of V pkCm in isolated OHCs. Thus, in evaluating OHC voltage-dependent movement and membrane capacitance, the effects of intracellular pressure have to be taken into account. In the present study, we used techniques to minimize or control for the effects of intracellular pressure. Under such conditions, it is clear that salicylate and lanthanides exert their effects independent of turgor pressure.
Two other reports have investigated the effects of salicylate on motility or membrane capacitance by the use of whole-cell voltage clamp Tunstall et al., 1995) . Neither controlled for pipette-mediated intracellular pressure changes, because large-tipped pipettes were used (2-5 M⍀, 1.5-3 m). Reduction of electromotility because of loss of turgidity by extracellularly applied salicylate was reported , and disruption of subsurface cisternae was thought to be related to this phenomenon . However, our data do not support their conclusions. First, salicylate suppresses Cm pk and shifts V pkCm to depolarized potentials-opposite the effects of decreasing turgor pressure. Second, extracellular salicylate application for up to 300 sec induced an apparent collapse of only one OHC (n ϭ 11) in whole-cell configuration with clamped, positive pressure. No unpatched, isolated cells showed any detectable collapse when 10 mM salicylate was applied extracellularly for Ͼ10 min, which is in accord with previous findings . In addition, only 2 of 11 OHCs tested with internal 10 mM Figure 8 . Effects of salicylate on the limited value of V pkCm . Intracellular pressure of the OHC was reduced directly through the patch pipette to collapse the cell. A, The cell was maintained in collapse after the point indicated by the first dotted line. As expected, collapsing the cell caused Cm pk to increase and V pkCm to shift to a limiting negative value (Kakehata and Santos-Sacchi, 1995) . At the second dotted line, 10 mM salicylate was applied extracellularly. V pkCm shifted in the positive direction with a decrease in Cm pk . Washout at the third dotted line caused recovery. B, Capacitance function determined by the stair-step protocol for the same cell. salicylate collapsed after 3 min. These time periods are far longer than necessary for the effects we observe on the sensor/motor. Third, in the OHCs treated with trypsin, in which the normal arrangement between membrane and subsurface cisternae is disrupted, effects of salicylate on the membrane voltage sensor remained. Thus, it is likely that the mechanisms of salicylate effects on the membrane sensor/motor and the subsurface cisternae are different and that the action of salicylate on the membrane sensor/motor is faster than that on the subsurface cisternae, which requires Ͼ10 min for detectable effects . Tunstall et al. (1995) reported values of the Hill coefficient (n) and half-maximal concentration (K 1/2 ) for salicylate of 3.40 and 3.95 mM, respectively. From these data they deduced that the sensor/motor within the OHC membrane is a tetramer, as originally suggested by Kalinec et al. (1992) . Our results indicate an n of 1.0 and K 1/2 of 1.6 mM. These apparent differences can be accounted for. Tunstall et al. obtained their dose-response curve at a fixed voltage of Ϫ50 mV, but they did not attempt to keep intracellular pressure constant. Measured capacitance at a fixed voltage may be subject to fluctuation induced by inadvertent turgor pressure change. Nevertheless, one cell was evaluated at four different membrane potentials with similar results, and data collection was rapid, indicating that pressure changes in their cells may not have been significantly influential. More importantly, however, their dose-response curves were obtained with a perfusion technique (monitoring the drug concentration increase near the cell after the start of a continuous flow of 10 mM salicylate), which presented salicylate for too short a period of time at low concentrations to allow Cm levels to reach steady state. As we demonstrated in this paper, tau of salicylate-induced reduction in Cm pk was 19.2 Ϯ 3.7 and 11.4 Ϯ 2.4 sec for 1 and 10 mM salicylate, respectively (see also Fig. 5 in Tunstall et al., 1995 ; tau of 5 mM salicylate-induced reduction in Cm is ϳ15 sec). Their Figure 8 indicates that exposure time at each measured concentration below 10 mM was no more than a few seconds, total perfusion time from 0 to 10 mM being 30 sec. Such short application times would make their dose-response curve steeper and K 1/2 larger than actual and also would account for the nonsymmetrical shape of their data.
In the present experiments, we obtained the concentrationresponse curve by measuring changes in the maximum capacitance of the cell (Cm pk ), and various concentrations of salicylate were applied for at least 120 sec, allowing steady levels to be reached. In addition, we attempted to control for the effects of inadvertent intracellular pressure change. Although the K 1/2 we observed was 1.6 mM, effects on the sensor/motor were observed in the hundred micromolar range. It has been shown that the perilymphatic salicylate concentration, which induces tinnitus and hearing loss in the rat, is near 400 M (Jastreboff et al., 1986) . Therefore, the data we obtain in vitro are in accord with in vivo results. The value of the Hill coefficient for salicylate obtained in this experiment is 1.0, which indicates that there is one binding site per sensor/motor molecule for salicylate. This type of information is not sufficient to speculate on the number of sensor/motor subunits but simply points to a lack of cooperativity.
Our data permit us to speculate on the site and mechanism of salicylate action. Salicylic acid, transported in the undissociated or unionized form, is highly permeable across lipid bilayers (Gutknecht and Tosteson, 1973) and human red cell membranes (Joy and Cutler, 1987) . When salicylic acid enters a cell, dissociation to salicylate occurs, with the final concentration of the dissociated form being dependent on intracellular pH (pHi). Because pHi decreases on application of extracellular salicylate under wholecell recording conditions (Tunstall et al., 1995) , the resulting level of intracellular salicylate at equilibrium is less than that of extracellular salicylate. Given the pKa of salicylic acid (3.0), it can be calculated from the Henderson-Hasselbalch equation that 0.6 M salicylic acid will exist as the undissociated form at a 10 mM extracellular concentration of salicylate anion. Assuming that extracellularly applied 10 mM salicylate causes pHi to shift from 7.2 to 6.9, then the concentration of salicylate inside the cell would be 5 mM at equilibrium. The actual pHi change would depend on the efficacy of the patch solution buffer. The relatively slow time Figure 9 . Effects of salicylate on V pkCm and Cm pk of a trypsin-treated cell. Trypsin (300 g/ml) was included in the patch pipette. After the cell became fully spherical at ϳ13 min, 10 mM salicylate was applied extracellularly. Voltage-dependent capacitance was measured before, during, and after application of salicylate. Salicylate reduced voltage-dependent capacitance reversibly, despite permanent disruption of the subsurface cisternae. course of salicylate action by extracellular perfusion may correspond to the time taken for salicylate to form intracellularly. In fact, Tunstall et al. (1995) showed that pHi changed from 7.2 to 6.9 in 30 sec. This time course should reflect directly the dissociation of H ϩ from salicylic acid. Because they also showed that pHi itself is not the main cause of capacitance decrease, we conclude that the change in capacitance that we note with extracellular salicylate is attributable to the production of the dissociated form. On the other hand, when 10 mM sodium salicylate solution buffered to pH 7.2 is introduced intracellularly, the effect is almost immediate and more pronounced, presumably because the dissociated form is delivered directly and at higher concentrations. It should be emphasized that, for either intracellular or extracellular application, the concentration of salicylic acid would be the same (0.6 M). That is, the residence of the uncharged form within the membrane probably does not interfere with the sensor/motor. Thus, our data, which demonstrate that salicylate acts faster and to a greater extent when dialyzed into the OHC, suggest that salicylate works on the sensor/motor in the dissociated, charged form. The ability of the dissociated, charged form of salicylate to interact with the sensor/motor on the inner aspect of the plasma membrane may underlie the voltage dependence shifts that we observe in the capacitance functions. Although salicylate is effective on the intracellular aspect of the lateral plasma membrane, we show that lanthanides function exclusively on the outer aspect. These results are contrary to those reported by Gale and Ashmore (1994a) .
The comparison between mechanical movements and charge movements in treated cells indicates that, whereas charge movement is suppressed to nearly the same extent by salicylate and lanthanides, motility is not. Mechanical responses remain substantial after salicylate treatment, but the motility function becomes linear between the range of Ϫ150 and ϩ150 mV. It should be noted, however, that in both cases residual nonlinear capacitance remains. The difference between mechanical responses obtained with the two treatments may relate to differential changes in the axial stiffness of the cell under each condition. It has been found that extracellularly applied salicylate reversibly reduces axial stiffness of isolated OHCs of guinea pig (Russell et al., 1995) , which may be related to the demonstration of a reversible decrease in OHC lateral wall stiffness (Lue et al., 1996) . Under such conditions, the residual charge movement may correspond to conformational changes of the motor molecule that are capable of driving an unloaded cell with reduced axial stiffness. Lanthanide treatment, on the other hand, may increase axial stiffness. This may be indicated by the elongation and apparent stiffening of the OHC noted with lanthanide treatments (Santos-Sacchi, 1991; Kakehata and Santos-Sacchi, 1995) . Under conditions of increased axial stiffness, the conformation change of the motor, indicated by the residual charge movement, may be unable to effect mechanical responses.
In conclusion, we show that salicylate and lanthanides do not work via mechanisms similar to changes in intracellular turgor pressure. The effects seem to be a result of direct action on the motility sensor/motor: lanthanides working on the external aspect of the lateral membrane and salicylates working on the intracellular aspect. It is interesting to note that simple modifications to the salicylate molecule, which would limit its entry into the OHC, are predicted to eliminate the attendant tinnitus and hearing loss associated with the ingestion of the drug.
